Overview

Treatment Plan to Provide Expanded Access to Stiripentol for Patients With Dravet Syndrome

Status:
Approved for marketing
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
Expanded access to Stiripentol for patients with Dravet Syndrome.
Details
Lead Sponsor:
Children's Hospital Medical Center, Cincinnati
Treatments:
Stiripentol